A32P (p.Ala32Pro) variant of RHO (Rhodopsin)

A32P (p.Ala32Pro) in RHO (Rhodopsin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Retinal dystrophy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes structural context.

A32P (p.Ala32Pro) variant details